Open-house discount agreements for Teduglutide 2026-09

Summary

The tender concerns an open-house framework of discount agreements for the medicinal product Teduglutide. The contracting authority aims to conclude non-exclusive agreements with all suitable pharmaceutical companies under uniform conditions. The contract term is generally up to 24 months, starting no earlier than 1 July 2026 and ending no later than 30 June 2028. Further participation details must be checked in the tender documents.